KR100243820B1 - 신규의 심장보호제 - Google Patents

신규의 심장보호제 Download PDF

Info

Publication number
KR100243820B1
KR100243820B1 KR1019940703514A KR19940703514A KR100243820B1 KR 100243820 B1 KR100243820 B1 KR 100243820B1 KR 1019940703514 A KR1019940703514 A KR 1019940703514A KR 19940703514 A KR19940703514 A KR 19940703514A KR 100243820 B1 KR100243820 B1 KR 100243820B1
Authority
KR
South Korea
Prior art keywords
tetramethyl
dihydro
compound
trans
benzopyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019940703514A
Other languages
English (en)
Korean (ko)
Other versions
KR950700896A (ko
Inventor
제이.마르뗑 그리사
마가레 아 쁘띠
프랑크 볼케니우스
Original Assignee
슈테펜엘.네스비트
메렐 다우 파마슈티칼스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 슈테펜엘.네스비트, 메렐 다우 파마슈티칼스 인크. filed Critical 슈테펜엘.네스비트
Publication of KR950700896A publication Critical patent/KR950700896A/ko
Application granted granted Critical
Publication of KR100243820B1 publication Critical patent/KR100243820B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Pyrane Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1019940703514A 1992-04-06 1993-03-08 신규의 심장보호제 Expired - Fee Related KR100243820B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP92400957 1992-04-06
EP92400957.4 1992-04-06
PCT/US1993/002102 WO1993020058A1 (en) 1992-04-06 1993-03-08 Novel cardioprotective agents

Publications (2)

Publication Number Publication Date
KR950700896A KR950700896A (ko) 1995-02-20
KR100243820B1 true KR100243820B1 (ko) 2000-03-02

Family

ID=8211647

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940703514A Expired - Fee Related KR100243820B1 (ko) 1992-04-06 1993-03-08 신규의 심장보호제

Country Status (18)

Country Link
EP (1) EP0635010B1 (cg-RX-API-DMAC7.html)
JP (1) JP3248183B2 (cg-RX-API-DMAC7.html)
KR (1) KR100243820B1 (cg-RX-API-DMAC7.html)
AT (1) ATE146175T1 (cg-RX-API-DMAC7.html)
AU (1) AU667889B2 (cg-RX-API-DMAC7.html)
CA (1) CA2132745C (cg-RX-API-DMAC7.html)
DE (1) DE69306559T2 (cg-RX-API-DMAC7.html)
DK (1) DK0635010T3 (cg-RX-API-DMAC7.html)
ES (1) ES2098030T3 (cg-RX-API-DMAC7.html)
FI (1) FI112658B (cg-RX-API-DMAC7.html)
GR (1) GR3022471T3 (cg-RX-API-DMAC7.html)
HU (1) HU217426B (cg-RX-API-DMAC7.html)
IL (1) IL105320A (cg-RX-API-DMAC7.html)
NO (1) NO307088B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ251131A (cg-RX-API-DMAC7.html)
TW (1) TW232014B (cg-RX-API-DMAC7.html)
WO (1) WO1993020058A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA932326B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions
CN115073413B (zh) * 2022-05-17 2023-06-02 中山大学 一种苯并环醚类倍半萜类化合物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947473A (en) * 1972-12-22 1976-03-30 Hoffman-La Roche Inc. Antioxidant chroman compounds
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs

Also Published As

Publication number Publication date
FI944656L (fi) 1994-10-05
EP0635010A1 (en) 1995-01-25
AU667889B2 (en) 1996-04-18
IL105320A (en) 1998-02-08
AU3797293A (en) 1993-11-08
JPH07505392A (ja) 1995-06-15
DE69306559T2 (de) 1997-04-10
HUT68982A (en) 1995-08-28
NO307088B1 (no) 2000-02-07
KR950700896A (ko) 1995-02-20
NO943727L (no) 1994-12-05
FI112658B (fi) 2003-12-31
CA2132745A1 (en) 1993-10-14
JP3248183B2 (ja) 2002-01-21
ES2098030T3 (es) 1997-04-16
DE69306559D1 (de) 1997-01-23
IL105320A0 (en) 1993-08-18
NO943727D0 (no) 1994-10-05
FI944656A0 (fi) 1994-10-05
WO1993020058A1 (en) 1993-10-14
TW232014B (cg-RX-API-DMAC7.html) 1994-10-11
NZ251131A (en) 1996-01-26
EP0635010B1 (en) 1996-12-11
ZA932326B (en) 1993-10-18
DK0635010T3 (da) 1996-12-30
HU9402863D0 (en) 1995-01-30
CA2132745C (en) 2000-03-21
ATE146175T1 (de) 1996-12-15
HU217426B (hu) 2000-01-28
GR3022471T3 (en) 1997-05-31

Similar Documents

Publication Publication Date Title
EP0202589B1 (en) Pharmaceutical compositions containing ascorbic acid derivatives
JP3230699B2 (ja) 心臓保護トコフェロ−ル類似体
WO2023099549A1 (en) Process for the synthesis and purification of cannabinoic acids and acylated derivatives thereof
JP3226185B2 (ja) 組織保護トコフェロ−ル類似体
EP0635010B1 (en) Novel cardioprotective agents
US5698696A (en) Process for preparing 2,3-dihydro-benzofuranol derivatives
JP3246741B2 (ja) ２，３−ジヒドロベンゾフラノールの新規な誘導体及びその製法
US5545660A (en) Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
US5510373A (en) Cardioprotective agents
CA2132831C (en) Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
US5500444A (en) Cardioprotective tocopherol analogs
Jovanović Review of the article „Synthesis and Evaluation of Novel Chromanone and Quinolinone Analogues of Uniflorol as Anti-Leishmanial Agents “, verified by Publons, Web of Science
AU705004B2 (en) 2,3-dihydro-benzofuranol derivatives and process for resolving the same
FR2875806A1 (fr) Preparation de composes phenol-amides a proprietes antioxidantes

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20031110

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20041119

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20041119